383.5500 -8.65 (-2.21%)
NSE Mar 13, 2026 15:31 PM
Volume: 4.8M
 

383.55
-2.21%
Axis Direct
We maintain our BUY rating on the stock with a target price of Rs 380/share, implying an 11% upside potential from the CMP.
Number of FII/FPI investors increased from 308 to 347 in Dec 2025 qtr.
More from Biocon Ltd.
All earning calls
Investor presentations from Biocon Ltd.
All investor presentations